FDA Inspection
Bell International Laboratories, Inc.Bell International Laboratories, Inc. – FDA Inspection, Sep 19, 2023
Record Details
This FDA Inspection record concerns Bell International Laboratories, Inc., with an inspection on September 19, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- September 19, 2023
- Product Type
- Drugs
View Company Profile
ID · 304b25e3-7560-4723-9486-3037acf8d2a7
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1218235
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- Warning Letter
Other FDA inspections of Bell International Laboratories, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 12, 2025 | Not classified | Minneapolis District Office | |
| June 22, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 29, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 14, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 26, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bell International Laboratories, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.